Vir Biotechnology, Inc.
VIR
$5.63
-$0.44-7.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.86M | 19.00M | 20.86M | 74.21M | 78.62M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.86M | 19.00M | 20.86M | 74.21M | 78.62M |
| Cost of Revenue | 455.38M | 499.15M | 506.80M | 487.72M | 505.30M |
| Gross Profit | -438.52M | -480.15M | -485.94M | -413.51M | -426.68M |
| SG&A Expenses | 95.16M | 98.67M | 106.65M | 119.03M | 133.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 550.54M | 597.82M | 613.45M | 606.75M | 638.84M |
| Operating Income | -533.68M | -578.82M | -592.59M | -532.54M | -560.23M |
| Income Before Tax | -499.39M | -549.95M | -579.05M | -523.11M | -539.19M |
| Income Tax Expenses | 268.00K | 277.00K | -1.41M | -1.15M | -5.84M |
| Earnings from Continuing Operations | -499.65 | -550.23 | -577.65 | -521.96 | -533.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | 0.00 |
| Net Income | -499.65M | -550.23M | -577.65M | -521.96M | -533.34M |
| EBIT | -533.68M | -578.82M | -592.59M | -532.54M | -560.23M |
| EBITDA | -522.01M | -567.26M | -579.68M | -517.98M | -544.07M |
| EPS Basic | -3.62 | -4.01 | -4.22 | -3.83 | -3.92 |
| Normalized Basic EPS | -2.21 | -2.39 | -2.43 | -2.12 | -2.23 |
| EPS Diluted | -3.62 | -4.01 | -4.22 | -3.83 | -3.93 |
| Normalized Diluted EPS | -2.21 | -2.39 | -2.43 | -2.12 | -2.23 |
| Average Basic Shares Outstanding | 551.66M | 549.38M | 547.16M | 544.97M | 542.77M |
| Average Diluted Shares Outstanding | 551.66M | 549.38M | 547.16M | 544.97M | 542.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |